Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
09 December 2009 An antibody deal with ex-parent company Novo Nordisk has given ZymoGenetics a financial boost, days after the latter announced another round of job cuts. Full Article at PharmaTimes
The Outlook for Pharmaceutical Markets in Northern Europe is a unique collection of management reports from Espicom Business Intelligence. Full Article at News-Medical.net
In this photo taken by Feature Photo Service: Max Szadek celebrates World Diabetes Day with one of the hundreds of women living with diabetes at the Divabetic - Makeover Your Diabetes event presented by Novo Nordisk on November 14, 2009 in New York City. View Photo »
Novo Nordisk is currently building a pipeline of products to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, lupus and inflammatory bowel disease
2009-12-09 12:29:39 - at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection. Full Article at PR-Inside.com
EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients' own 'natural killer' cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma. Full Article at EurekAlert
Today Eleanor Malone Please Login to read the full article. Full Article at Scrip News
Health Across America national campaign sponsors, supporters, and spokespeople during the May 9 kick-off event in San Diego include (left-right): Emily Blake, senior account executive at Novo Nordisk; Chris Evans, national account manager at Bayer Diabe... View Photo »
Puducherry, India, December 8 — According to a new study, fear of gaining weight has forced many diabetic women and teenagers in limiting their use of insulin, which can cause damage to their health. Full Article at 24x7updates
08 December 2009 Novo Nordisk has initiated its first Phase I trial with an oral insulin analogue, called NN1952, which it hopes could one day provide an alternative to daily injections for diabeties patients. Full Article at PharmaTimes
There are no results for this module. Edit this module to change the search term used to query Wikipedia
In this photo taken by Feature Photo Service: Max Szadek celebrates World Diabetes Day with one of the hundreds of women living with diabetes at the Divabetic - Makeover Your Diabetes event presented by Novo Nordisk on November 14, 2009 in New York City.
View Photo »Health Across America national campaign sponsors, supporters, and spokespeople during the May 9 kick-off event in San Diego include (left-right): Emily Blake, senior account executive at Novo Nordisk; Chris Evans, national account manager at Bayer Diabetes Care; Lisa Gordon, director of...
View Photo »John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (Friday 16th January 2009) of Merrion's second $58m contract with Novo Nordisk.
View Photo »John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (Friday 16th January 2009) of Merrion's second $58m contract with Novo Nordisk.
View Photo »Health Across America national campaign sponsors, supporters, and spokespeople during the May 9 kick-off event in San Diego include (left-right): Emily Blake, senior account executive at Novo Nordisk; Chris Evans, national account manager at Bayer Diabetes Care; Lisa Gordon, director of...
View Photo »Novo Nordisk is currently building a pipeline of products to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, lupus and inflammatory bowel disease
India's share in Novo Nordisk's global turnover is negligible — around 1-1.5 per cent. But it is steadily growing at a rate of 20-30 per cent
The new facility will comply with the stringent quality norms practiced globally by Novo Nordisk. Torrent Pharma is the manufacturer of Insulin Formulations for Novo Nordisk in India since 1992.
The new facility is an integrated manufacturing and vial packaging plant with a capacity to manufacture 26 million vials annually with an investment of USD 11 million. Insulin is formulated from insulin crystals supplied by Novo Nordisk, Denmark.
This move isn't that surprising and comes as Amylin is awaiting approval for its highly anticipated compound Byetta LAR ... Considering how Novo Nordisk ( NVO - news - people ) plans to market Victoza when it receives FDA approval, this relationship with Takeda provides Amylin with some additional marke...
Many families impacted by hemophilia with inhibitors struggle to find tools, resources and support ... Through changingpossibilities-us.com and the changing possibilities in hemophilia(TM) Facebook Page, Novo Nordisk hopes to provide members of the inhibitor community with a unique forum to share and le...
Many families impacted by hemophilia with inhibitors struggle to find tools, resources and support ... Through changingpossibilities-us.com and the Facebook Page, Novo Nordisk hopes to provide members of the inhibitor community with a unique forum to share and learn from others' experiences.
Novo Nordisk continues the constructive dialog with the FDA regarding the regulatory process for liraglutide
There are no results for this module. Edit the module to change the search term used to query Twitter.
